VFF Stock Loses 27% in Three Months: Time to Invest or Exit?

Village Farms’ shares are down 27% over the past three months even as it posted first-quarter 2026 revenue growth that beat expectations. Management points to robust international cannabis demand—especially in Europe—with record export sales and capacity expansions that support longer-term growth. The positive fundamentals appear outweighed by investor sentiment and/or other near-term concerns.

Analysis

The market is signaling that top-line growth is not being treated as value-creating until it translates into cash. In cannabis, export growth often looks cleaner than domestic sales but can still be low-quality if it comes with higher compliance costs, working-capital drag, and uneven pricing; that is why the equity can de-rate even on a good revenue print. The immediate losers are likely other Canadian growers with excess greenhouse capacity and weaker international channels, because any incremental supply chasing Europe tends to keep the industry in a price/ROIC squeeze rather than a pure volume upcycle.

The next catalyst is not another revenue beat but proof of operating leverage over the next 1-2 quarters: gross margin, EBITDA, inventory turns, and operating cash flow. If capacity expansion is ahead of demand, the company risks turning a promising sales story into higher capex and receivables without free-cash-flow conversion, which would keep the multiple compressed for months. The structural upside case only works if Europe becomes recurring contracted demand rather than opportunistic spot exports; that would justify a re-rating relative to domestic-only peers and cannabis ETFs such as MSOS.

Contrarianly, the selloff may be too severe if the export channel is becoming sticky and the company is one of the few names in the space with real international distribution. But the burden of proof is high: the stock needs evidence that incremental sales are margin-accretive, not just growth for growth’s sake. Falsifiers are simple: any margin compression, weak cash conversion, or guidance that implies capacity is outpacing demand should keep us cautious rather than buying the dip.

Key Decisions for Investors

• Do not chase the revenue print; wait for the next quarterly release to verify gross margin and operating cash flow before adding exposure. If EBITDA margin and FCF do not improve, treat the recent weakness as justified rather than a dip to buy.
• For a tactical relative-value expression, consider a small long VFF / short TLRY or CGC basket over the next 1-3 months only if management shows export mix is becoming recurring and margin-accretive. Thesis fails if VFF's gross margin slips or cash burn persists.
• If you want optionality on a Europe-led rerating, use a limited-risk call spread into the next earnings event rather than outright stock. Size modestly; the key risk is that growth remains capital-intensive and the multiple keeps compressing.
• Set an alert for the next quarter's operating cash flow and inventory build. A positive FCF inflection is the real catalyst; absent that, the market will likely continue to value VFF as a low-quality grower despite the top-line growth.